<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39315693</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-0012</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical transplantation</Title><ISOAbbreviation>Clin Transplant</ISOAbbreviation></Journal><ArticleTitle>Evaluation of Virtual Care in Kidney Transplant Recipients in the Early Posttransplant Period.</ArticleTitle><Pagination><StartPage>e15459</StartPage><MedlinePgn>e15459</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ctr.15459</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Though virtual care was widely adopted during the COVID-19 pandemic, evidence to support its use in kidney transplant recipients early after transplantation is limited.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study comparing post kidney transplant outcomes in patients who received in-person transplant care before the COVID-19 pandemic with those who received mainly virtual transplant care during the COVID-19 pandemic. The usual-care group included 69 patients who received a kidney transplant from March 1, 2019 to September 1, 2019, and the virtual-care group included 64 patients who received a kidney transplant from September 1, 2020 to March 1, 2021.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At 6 months, five patients in the usual-care group and three patients in the virtual-care group died. There was one graft loss and one episode of acute rejection in the usual-care group, and two episodes of acute rejection in the virtual-care group (p = 0.60). Estimated glomerular filtration rate was higher for patients in the virtual-care group (59 mL/min/1.73 m<sup>2</sup> vs. 52 mL/min/1.73 m<sup>2</sup>, p = 0.046) and serum creatinine was not different (138 µmol/L vs. 127 µmol/L, p = 0.27). There was no difference in mean blood pressure or hospitalizations.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Outcomes were similar among recipients of a kidney transplant prior to the COVID-19 pandemic when care was mainly in person and during the pandemic when care was mainly virtual, without a signal of harm. Patient and donor selection may have led to unmeasured differences between groups.</AbstractText><CopyrightInformation>© 2024 The Author(s). Clinical Transplantation published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almarzouk</LastName><ForeName>Saad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alazwari</LastName><ForeName>Monther</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0000-7903-1210</Identifier><AffiliationInfo><Affiliation>Department of Nephrology and Kidney Transplant, Armed Forces Hospital, Taif, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matias</LastName><ForeName>Evangelyn Grace</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Renal and Metabolic Division, Philippine Heart Center, Quezon City, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clase</LastName><ForeName>Catherine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methodology, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yohanna</LastName><ForeName>Seychelle</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0404-7319</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Clin Transplant</MedlineTA><NlmUniqueID>8710240</NlmUniqueID><ISSNLinking>0902-0063</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006084" MajorTopicYN="Y">Graft Rejection</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006085" MajorTopicYN="N">Graft Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066027" MajorTopicYN="N">Transplant Recipients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinic</Keyword><Keyword MajorTopicYN="N">kidney transplant</Keyword><Keyword MajorTopicYN="N">quality</Keyword><Keyword MajorTopicYN="N">virtual care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>8</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39315693</ArticleId><ArticleId IdType="doi">10.1111/ctr.15459</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>F. Al Ammary, C. Sidoti, D. L. Segev, and M. L. Henderson, “Health Care Policy and Regulatory Challenges for Adoption of Telemedicine in Kidney Transplantation,” American Journal of Kidney Diseases 77 (2021): 773–776, https://doi.org/10.1053/j.ajkd.2020.09.013.</Citation></Reference><Reference><Citation>S. K. Mistry, M. Shaw, F. Raffan, et al., “Inequity in Access and Delivery of Virtual Care Interventions: A Scoping Review,” International Journal of Environmental Research and Public Health 19 (2022): 9411.</Citation></Reference><Reference><Citation>M. Lunney, A. Samimi, M. A. Osman, et al., “Capacity of Kidney Care in Canada: Identifying Barriers and Opportunities,” Canadian Journal of Kidney Health and Disease 6 (2019): 2054358119870540, https://doi.org/10.1177/2054358119870540.</Citation></Reference><Reference><Citation>R. Erdmann, L. Morrin, R. Harvey, L. Joya, A. Clifford, and S. Soroka, “Canadian Senior Renal Leaders Community of Practice: Vulnerable Populations With Chronic Kidney Disease‐Evidence to Inform Policy,” Canadian Journal of Kidney Health and Disease 7 (2020): 2054358120930977, https://doi.org/10.1177/2054358120930977.</Citation></Reference><Reference><Citation>D. Collister, L. Pyne, J. Cunningham, et al., “Multidisciplinary Chronic Kidney Disease Clinic Practices: A Scoping Review,” Canadian Journal of Kidney Health and Disease 6 (2019): 2054358119882667, https://doi.org/10.1177/2054358119882667.</Citation></Reference><Reference><Citation>C. W. Teoh, M. M. Gaudreault‐Tremblay, T. D. Blydt‐Hansen, et al., “Management of Pediatric Kidney Transplant Patients During the COVID‐19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group,” Canadian Journal of Kidney Health and Disease 7 (2020): 2054358120967845, https://doi.org/10.1177/2054358120967845.</Citation></Reference><Reference><Citation>“Automobile Allowance Rates,” accessed May 1, 2022, https://www.canada.ca/en/revenue‐agency/services/tax/businesses/topics/payroll/benefits‐allowances/automobile/automobile‐motor‐vehicle‐allowances/automobile‐allowance‐rates.html.</Citation></Reference><Reference><Citation>L. A. Inker, C. H. Schmid, H. Tighiouart, et al., “Estimating Glomerular Filtration Rate From Serum Creatinine and Cystatin C,” New England Journal of Medicine 367 (2012): 20–29, https://doi.org/10.1056/NEJMoa1114248.</Citation></Reference><Reference><Citation>J. H. Chang, M. Diop, Y. L. Burgos, et al., “Telehealth in Outpatient Management of Kidney Transplant Recipients During COVID‐19 Pandemic in New York,” Clinical Transplantation 34 (2020): e14097, https://doi.org/10.1111/ctr.14097.</Citation></Reference><Reference><Citation>S. Lambooy, R. Krishnasamy, A. Pollock, G. Hilder, and N. A. Gray, “Telemedicine for Outpatient Care of Kidney Transplant and CKD Patients,” Kidney International Reports 6 (2021): 1265–1272, https://doi.org/10.1016/j.ekir.2021.02.016.</Citation></Reference><Reference><Citation>A. Schmid, S. Hils, A. Kramer‐Zucker, et al., “Telemedically Supported Case Management of Living‐Donor Renal Transplant Recipients to Optimize Routine Evidence‐Based Aftercare: A Single‐Center Randomized Controlled Trial,” American Journal of Transplantation 17 (2017): 1594–1605, https://doi.org/10.1111/ajt.14138.</Citation></Reference><Reference><Citation>N. Andrew, K. A. Barraclough, K. Long, et al., “Telehealth Model of Care for Routine Follow Up of Renal Transplant Recipients in a Tertiary Centre: A Case Study,” Journal of Telemedicine and Telecare 26 (2020): 232–238, https://doi.org/10.1177/1357633X18807834.</Citation></Reference><Reference><Citation>V. Stamenova, C. Chu, A. Pang, M. Tadrous, R. S. Bhatia, and P. Cram, “Using Administrative Data to Explore Potentially Aberrant Provision of Virtual Care During COVID‐19: Retrospective Cohort Study of Ontario Provincial Data,” Journal of Medical Internet Research [Electronic Resource] 23 (2021): e29396, https://doi.org/10.2196/29396.</Citation></Reference><Reference><Citation>V. Stamenova, C. Chu, A. Pang, M. Tadrous, R. S. Bhatia, and P. Cram, “Virtual Care Use During the COVID‐19 Pandemic and Its Impact on Healthcare Utilization in Patients With Chronic Disease: A Population‐Based Repeated Cross‐Sectional Study,” PLoS ONE 17 (2022): e0267218, https://doi.org/10.1371/journal.pone.0267218.</Citation></Reference><Reference><Citation>G. C. Alexander, M. Tajanlangit, J. Heyward, O. Mansour, D. M. Qato, and R. S. Stafford, “Use and Content of Primary Care Office‐Based vs Telemedicine Care Visits During the COVID‐19 Pandemic in the US,” JAMA Network Open 3 (2020): e2021476, https://doi.org/10.1001/jamanetworkopen.2020.21476.</Citation></Reference><Reference><Citation>J. Wolf, J. Rubin, A. Bossie, and J. Lizcano, “Acceptance of Telemedicine by Kidney Transplant Recipients During the COVID‐19 Pandemic: A Survey Study of Patient Experiences,” Trends in Transplantation 14 (2021): 1–4, https://doi.org/10.15761/TiT.1000294.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>